Clinical Trial Update: A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for ZYNRELEF (HTX-011) in analgesia completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Analgesia

Drugs mentioned

• ZYNRELEF (BUPIVACAINE AND MELOXICAM)

Snippet

Sponsor: Heron Therapeutics | Conditions: Analgesia | Phase 4 | Status: COMPLETED